Thus, plasma levels of CRP do not seem to have a direct causal effect on CAD risk, but can still act as a molecular readout (biomarker) of the IL6R-mediated inflammatory response that does seem to have a causal effect72. The gene discussed is IL6R; the disease is coronary artery disorder.